Introductions from Jim Leonard, MHA, Vice President, West and South Sound Markets for Group Health Cooperative and from Marc Mora, MD, Medical Director, Consultative Specialty Services for Group Health.
Introduction to the Tacoma/Pierce County CME
B vitamins in patients with recent transient ischaemichospital
1) The VITATOPS trial studied whether daily supplements of B vitamins (folic acid, B6, B12) would lower homocysteine levels and reduce the risk of stroke, heart attack, or vascular death in patients with a recent stroke or transient ischemic attack.
2) The trial involved over 8,000 patients from 20 countries randomly assigned to receive either B vitamins or placebo daily for an average of 3.4 years.
3) While homocysteine levels were significantly lower in those receiving B vitamins, the treatment did not significantly reduce the combined risk of stroke, heart attack, or vascular death compared to placebo.
This document discusses the impact of drug-eluting stents on Medicare and other stakeholders. It introduces drug-eluting stents as a major breakthrough for treating heart disease. While these stents are more effective than traditional treatments, they also significantly increase costs. For Medicare, the short-term cost of each procedure reimbursed rises by $2,800, increasing total Medicare expenditures by around $400 million. However, drug-eluting stents may save $2,500 per patient annually by reducing future procedures. Hospitals face short-term losses from lower reimbursements compared to costs for each stent procedure. Long-term, hospitals could see declines in more profitable bypass surgeries as stents are increasingly used.
This document presents a systematic review and meta-analysis examining the risk of adverse neurological events from radial versus femoral artery access for cardiac catheterization. The review found a stroke rate of 0.14% for radial access versus 0.19% for femoral access based on over 500,000 procedures. Specifically, it found no increased risk of ischaemic or haemorrhagic stroke with radial compared to femoral access. The conclusions were that radial access is not associated with an increased risk of stroke events compared to femoral access.
1) EndoPAT is a medical device that noninvasively assesses endothelial function through changes in vascular tone in the fingers in response to induced hyperemia in the arm.
2) It has been validated in studies comparing it to measures of coronary and brachial artery endothelial function and shown to detect a nitric oxide mediated response.
3) Advantages of EndoPAT include simultaneous recording from both arms to control for systemic changes, assessment of occlusion quality, large dynamic range of measurements, and ease of use.
Allied Cooperative Insurance Group (ACIG) is a Saudi joint stock company established in accordance with royal decree to provide Sharia-compliant cooperative insurance products like property, motor, medical, and group life. ACIG manages insurance portfolios for the benefit of participants rather than for company profits. It has a vision to become the preferred cooperative insurance company in the region providing security to customers through high international standards. ACIG's products include medical, motor vehicle, general accident, money, fidelity, personal accident, and other insurance types. It also provides reinsurance through a panel of top global reinsurers.
This document appears to be a questionnaire for evaluating the performance of cooperatives. It contains several sections that evaluate different aspects of cooperative performance, including organizational leadership, human resource management, members, structure, systems and mechanisms, and social and economic aspects. Each section contains multiple questions to assess specific standards, along with the means of verification and point values assigned. The overall aim is to conduct a comprehensive performance audit of cooperatives using this 74-point questionnaire.
K. David McCowen, MD, FACP, Medical Director, Diabetes
Endocrine Consultants Northwest for Franciscan Medical Group. Talking about diabetes prevention best practices.
B vitamins in patients with recent transient ischaemichospital
1) The VITATOPS trial studied whether daily supplements of B vitamins (folic acid, B6, B12) would lower homocysteine levels and reduce the risk of stroke, heart attack, or vascular death in patients with a recent stroke or transient ischemic attack.
2) The trial involved over 8,000 patients from 20 countries randomly assigned to receive either B vitamins or placebo daily for an average of 3.4 years.
3) While homocysteine levels were significantly lower in those receiving B vitamins, the treatment did not significantly reduce the combined risk of stroke, heart attack, or vascular death compared to placebo.
This document discusses the impact of drug-eluting stents on Medicare and other stakeholders. It introduces drug-eluting stents as a major breakthrough for treating heart disease. While these stents are more effective than traditional treatments, they also significantly increase costs. For Medicare, the short-term cost of each procedure reimbursed rises by $2,800, increasing total Medicare expenditures by around $400 million. However, drug-eluting stents may save $2,500 per patient annually by reducing future procedures. Hospitals face short-term losses from lower reimbursements compared to costs for each stent procedure. Long-term, hospitals could see declines in more profitable bypass surgeries as stents are increasingly used.
This document presents a systematic review and meta-analysis examining the risk of adverse neurological events from radial versus femoral artery access for cardiac catheterization. The review found a stroke rate of 0.14% for radial access versus 0.19% for femoral access based on over 500,000 procedures. Specifically, it found no increased risk of ischaemic or haemorrhagic stroke with radial compared to femoral access. The conclusions were that radial access is not associated with an increased risk of stroke events compared to femoral access.
1) EndoPAT is a medical device that noninvasively assesses endothelial function through changes in vascular tone in the fingers in response to induced hyperemia in the arm.
2) It has been validated in studies comparing it to measures of coronary and brachial artery endothelial function and shown to detect a nitric oxide mediated response.
3) Advantages of EndoPAT include simultaneous recording from both arms to control for systemic changes, assessment of occlusion quality, large dynamic range of measurements, and ease of use.
Allied Cooperative Insurance Group (ACIG) is a Saudi joint stock company established in accordance with royal decree to provide Sharia-compliant cooperative insurance products like property, motor, medical, and group life. ACIG manages insurance portfolios for the benefit of participants rather than for company profits. It has a vision to become the preferred cooperative insurance company in the region providing security to customers through high international standards. ACIG's products include medical, motor vehicle, general accident, money, fidelity, personal accident, and other insurance types. It also provides reinsurance through a panel of top global reinsurers.
This document appears to be a questionnaire for evaluating the performance of cooperatives. It contains several sections that evaluate different aspects of cooperative performance, including organizational leadership, human resource management, members, structure, systems and mechanisms, and social and economic aspects. Each section contains multiple questions to assess specific standards, along with the means of verification and point values assigned. The overall aim is to conduct a comprehensive performance audit of cooperatives using this 74-point questionnaire.
K. David McCowen, MD, FACP, Medical Director, Diabetes
Endocrine Consultants Northwest for Franciscan Medical Group. Talking about diabetes prevention best practices.
Eric Herman, MD, Medical Director, Population Health and Family Physician, for MultiCare's Kent Clinic, talked about the power of the EMR is only as good as the person using it.
This document discusses the concept of a learning healthcare system where each patient experience contributes to the evidence base to continuously improve care. It notes that an ideal system provides up-to-date, unbiased, personalized information to patients when and where they want it. However, two cultural challenges remain - acting under uncertainty and improving transparency and trust between providers, health systems, and patients. The document argues that as an integrated, cooperative system, Group Health is well-positioned to help lead the transition to a true learning healthcare system.
Engines of Success for U.S. Health Reform?
Eric B. Larson, MD, MPHVice President for Research, Group Health Executive Director, Group Health Research Institute
This document discusses the opioid crisis in the United States and strategies to address it. It summarizes that national norms changed in the late 1990s to allow greater opioid prescribing without dosing guidance, which contributed to increased opioid-related deaths. The document recommends seeking help if opioid doses reach 120 mg/day of morphine equivalent and pain and function have not improved. It also outlines Washington state's opioid dosing guidelines and legislation aimed at curbing opioid overprescribing and related deaths.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502.
Presentation by Andrew Kolodny, M.D., chair, department of Psychiatry Maimonides Medical Center Brooklyn, New York
This document summarizes barriers to opioid monitoring in primary care as presented by Dr. Erin Krebs. Some key barriers include short appointment times that limit monitoring, an assumption that opioids are effective without formally assessing benefits, overconfidence in risk perceptions, and negative attitudes viewing monitoring as "policing" rather than patient care. Implications discussed are formally assessing opioid benefits, addressing expectations and readiness to change, maintaining focus on medication harms rather than patient trustworthiness, and developing systems to support recommended monitoring practices.
Implementing chronic opioid therapy guidelines at Group Health CooperativeGroup Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by, Grant Scull MD, associate director for Group Health Family Medicine Residency
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
Shared decision making involves doctors sharing information with patients about treatment options so patients can consider their options and make decisions together with their doctors. Decision aids like brochures and websites provide information to help patients make informed decisions by clarifying their values and preferences and guiding communication with doctors. Studies show decision aids increase patient knowledge and participation, align choices with values, and lower surgery rates without worse outcomes. Group Health implemented decision aid use for several conditions and is evaluating the impact on surgery rates, costs, and patient and provider experiences and identifying areas for improvement.
The document discusses the medical home model of patient-centered primary care. It outlines the challenges currently facing primary care and describes the design principles of the medical home model, which aims to improve care coordination, access, and patient engagement. Pilot outcomes data from Group Health showed improved quality measures, patient/staff satisfaction, and reduced costs with the medical home model over 2 years.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Eric Herman, MD, Medical Director, Population Health and Family Physician, for MultiCare's Kent Clinic, talked about the power of the EMR is only as good as the person using it.
This document discusses the concept of a learning healthcare system where each patient experience contributes to the evidence base to continuously improve care. It notes that an ideal system provides up-to-date, unbiased, personalized information to patients when and where they want it. However, two cultural challenges remain - acting under uncertainty and improving transparency and trust between providers, health systems, and patients. The document argues that as an integrated, cooperative system, Group Health is well-positioned to help lead the transition to a true learning healthcare system.
Engines of Success for U.S. Health Reform?
Eric B. Larson, MD, MPHVice President for Research, Group Health Executive Director, Group Health Research Institute
This document discusses the opioid crisis in the United States and strategies to address it. It summarizes that national norms changed in the late 1990s to allow greater opioid prescribing without dosing guidance, which contributed to increased opioid-related deaths. The document recommends seeking help if opioid doses reach 120 mg/day of morphine equivalent and pain and function have not improved. It also outlines Washington state's opioid dosing guidelines and legislation aimed at curbing opioid overprescribing and related deaths.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502.
Presentation by Andrew Kolodny, M.D., chair, department of Psychiatry Maimonides Medical Center Brooklyn, New York
This document summarizes barriers to opioid monitoring in primary care as presented by Dr. Erin Krebs. Some key barriers include short appointment times that limit monitoring, an assumption that opioids are effective without formally assessing benefits, overconfidence in risk perceptions, and negative attitudes viewing monitoring as "policing" rather than patient care. Implications discussed are formally assessing opioid benefits, addressing expectations and readiness to change, maintaining focus on medication harms rather than patient trustworthiness, and developing systems to support recommended monitoring practices.
Implementing chronic opioid therapy guidelines at Group Health CooperativeGroup Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by, Grant Scull MD, associate director for Group Health Family Medicine Residency
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
Shared decision making involves doctors sharing information with patients about treatment options so patients can consider their options and make decisions together with their doctors. Decision aids like brochures and websites provide information to help patients make informed decisions by clarifying their values and preferences and guiding communication with doctors. Studies show decision aids increase patient knowledge and participation, align choices with values, and lower surgery rates without worse outcomes. Group Health implemented decision aid use for several conditions and is evaluating the impact on surgery rates, costs, and patient and provider experiences and identifying areas for improvement.
The document discusses the medical home model of patient-centered primary care. It outlines the challenges currently facing primary care and describes the design principles of the medical home model, which aims to improve care coordination, access, and patient engagement. Pilot outcomes data from Group Health showed improved quality measures, patient/staff satisfaction, and reduced costs with the medical home model over 2 years.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Understanding functional status is important as it will give us an idea of who is going to cost the most in the future – having chronic conditions and multiple ones predicts increased costs, but functional status impairments are a greater predictor.